| Product Code: ETC9963634 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Crohn's Disease Diagnostics and Therapeutics Market - Industry Life Cycle |
3.4 United States (US) Crohn's Disease Diagnostics and Therapeutics Market - Porter's Five Forces |
3.5 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume Share, By Diagnostics, 2021 & 2031F |
3.6 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
4 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of Crohn's disease in the United States |
4.2.2 Technological advancements in diagnostic tools and treatment options |
4.2.3 Growing awareness and healthcare expenditure for chronic diseases |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval of diagnostics and therapeutics |
4.3.2 High cost associated with specialized diagnostics and biologic therapies |
5 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Trends |
6 United States (US) Crohn's Disease Diagnostics and Therapeutics Market, By Types |
6.1 United States (US) Crohn's Disease Diagnostics and Therapeutics Market, By Diagnostics |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.3 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Blood Test, 2021- 2031F |
6.1.4 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Fecal Test, 2021- 2031F |
6.1.5 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Colonoscopy, 2021- 2031F |
6.1.6 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Flexible Sigmoidoscopy, 2021- 2031F |
6.1.7 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Computerised Tomography, 2021- 2031F |
6.1.8 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Magnetic Resonance Imaging, 2021- 2031F |
6.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenues & Volume, By Surgery, 2021- 2031F |
7 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Import-Export Trade Statistics |
7.1 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Export to Major Countries |
7.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Imports from Major Countries |
8 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Key Performance Indicators |
8.1 Rate of adoption of new diagnostic technologies |
8.2 Patient satisfaction with the effectiveness of therapeutics |
8.3 Number of clinical trials focusing on Crohn's disease diagnostics and therapeutics |
9 United States (US) Crohn's Disease Diagnostics and Therapeutics Market - Opportunity Assessment |
9.1 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Opportunity Assessment, By Diagnostics, 2021 & 2031F |
9.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Opportunity Assessment, By Treatment, 2021 & 2031F |
10 United States (US) Crohn's Disease Diagnostics and Therapeutics Market - Competitive Landscape |
10.1 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Crohn's Disease Diagnostics and Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here